SCHEMBL9683745

SCHEMBL9683745

C[C@@H](CCc1ccc(C(N)=O)s1)N(C[C@H](O)COc1ccccc1)[C@H](O)Cc1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 14/20 0.44
ALDH1A1 P00352 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
MAPT P10636 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
POLB P06746 1/20 0.39
ADRB2 P07550 1/20 0.38
ADRB1 P08588 1/20 0.38
ADRB3 P13945 1/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
GAA P10253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9683712 0.90 PTGER4 (0.40) ABCB1CYP1A2CYP2D6CYP2C9ADRB1
SCHEMBL9684091 0.86 ABCB1 (0.42) ABCB1ALDH1A1CYP1A2CYP2D6MAPT
SCHEMBL9684099 0.86 ABCB1 (0.42) ABCB1ALDH1A1CYP1A2CYP2D6MAPT
SCHEMBL9811916 0.83 ABCB1 (0.54) ABCB1ALDH1A1CYP1A2CYP2D6MAPT
SCHEMBL9787439 0.80 ABCB1 (0.46) ABCB1CYP2D6POLBADRB2ADRB1
SCHEMBL9787435 0.80 ABCB1 (0.46) ABCB1CYP2D6POLBADRB2ADRB1
SCHEMBL9812008 0.78 ABCB1 (0.53) ABCB1ALDH1A1CYP1A2CYP2D6MAPT
SCHEMBL9683741 0.78 ABCB1 (0.36) ABCB1ALDH1A1CYP1A2CYP2D6MAPT
SCHEMBL9683733 0.78 ABCB1 (0.36) ABCB1ALDH1A1CYP1A2CYP2D6MAPT
SCHEMBL9684886 0.77 ALDH1A1 (0.47) ABCB1ALDH1A1CYP1A2CYP2D6MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5166218-A Antilipemic agents or antiglycemic agents HOFFMANN-LA ROCHE INC. (US) 1992-11-24 US disclosed
US-5064863-A Catabolic activity, obesity, diabetes HOFFMANN-LA ROCHE INC. (US) 1991-11-12 US disclosed